FA
MRNA icon

Fountainhead AM’s Moderna MRNA Stock Holding History

Fountainhead AM’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.9K Buy
1,383
+901
+187% +$46.6K 0.07% 134
2026
Q1 		$24.5K Buy
+482
New +$22.5K 0.02% 173
2022
Q1 		– Sell
-1,421
Closed -$361K – 79
2021
Q4 		$361K Hold
1,421
– – 0.16% 48
2021
Q3 		$547K Buy
+1,421
New +$524K 0.26% 33

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Fountainhead AM's MRNA Position: Q2 2026 in Review

Fountainhead AM increased its Moderna (MRNA) stake by 187% in Q2 2026, buying an estimated $46.6K and bringing the position to 1,383 shares worth $96.9K. The position accounts for 0.07% of the portfolio, ranked #134.

Fountainhead AM first reported a position in MRNA in Q3 2021 and has held it in 4 quarters since. The position peaked at $547K in Q3 2021. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Fountainhead AM held 1,383 shares of Moderna worth $96.9K as of Q2 2026.
  • Fountainhead AM bought 901 Moderna shares in Q2 2026, an estimated $46.6K.
  • Moderna made up 0.07% of Fountainhead AM's portfolio in Q2 2026, its #134 holding.
  • Fountainhead AM first reported a position in Moderna in Q3 2021 and has held it in 4 quarters since.
  • Fountainhead AM's Moderna position peaked at $547K in Q3 2021.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Fountainhead AM's 13F filing for Q2 2026, filed 3 Aug 2026.